FGF2 and melanoma: Using three melanoma cell lines which are dependent on oncogenic KIT, we showed that FGF2 drastically reduced the effect of the different KIT inhibitors pointing to an important role of the FGF2/FGFR axis in the resistance to KIT inhibitors.